Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Patient Advocacy Group Welcomes Recommendation

Patient Advocacy Group Welcomes Royal Commission's Recommendations

The New Zealand Organisation for Rare Disorders is delighted with the health and research recommendations in the report of the Royal Commission on Genetic Modification.

NZORD Executive Director, John Forman, said there is great relief among patients and their families that the Commission has rejected any restriction on access to vital medicines obtained from genetic modification technology.

"The Commission's report acknowledges the benefits to be gained from further development of such medicines, and the great potential for gene therapy and other novel therapies to treat disease.

"We are very pleased they have supported these objectives by recommending a streamlining and simplification of new research approval processes, and for the approval of new medicines produced", said Mr Forman. "That will help speed the research efforts and produce more treatments sooner.

"NZORD also welcomes the Commission's endorsement of the safety regimes governing such research, and the recommendations for reinforcement of the ethical oversight of the application of this new technology.

"Safety and ethics are of vital interest to families affected by rare and complex disorders, and the recommendations will help to ensure our and the public's confidence in the safety and beneficial application of genetic modification.

"NZORD looks forward to speedy implementation of the report by Government", Mr Forman concluded.

Ends

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
GenPro: General Practices Begin Issuing Clause 14 Notices

GenPro has been copied into a rising number of Clause 14 notices issued since the NZNO lodged its Primary Practice Pay Equity Claim against General Practice employers in December 2023.More

SPADA: Screen Industry Unites For Streaming Platform Regulation & Intellectual Property Protections

In an unprecedented international collaboration, representatives of screen producing organisations from around the world have released a joint statement.More

 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.